Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M, Ünal S, Schlegel M, Ader F, Lacombe K, Amdal CD, Rodrigues S, Tonby K, Gaudet A, Heggelund L, Mootien J, Johannessen A, Møller JH, Pollan BD, Tveita AA, Kildal AB, Richard JC, Dalgard O, Simensen VC, Baldé A, de Gastines L, Del Álamo M, Aydin B, Lund-Johansen F, Trabaud MA, Diallo A, Halvorsen B, Røttingen JA, Tacconelli E, Yazdanpanah Y, Olsen IC, Costagliola D; EU SolidAct study group. Trøseid M, et al. Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8. Crit Care. 2023. PMID: 36627655 Free PMC article. Clinical Trial.
Coronary revascularisation deferral based on quantitative flow ratio or fractional flow reserve: a post hoc analysis of the FAVOR III Europe trial.
Andersen BK, Holm NR, Mogensen LJH, Maillard L, Råmunddal T, Erriquez A, Christiansen EH, Escaned J, Of The Favor Iii Europe Study Team OB. Andersen BK, et al. EuroIntervention. 2025 Jan 2:EIJ-D-24-01001. doi: 10.4244/EIJ-D-24-01001. Online ahead of print. EuroIntervention. 2025. PMID: 39750037 Free article.
A pulsar-like polarization angle swing from a nearby fast radio burst.
Mckinven R, Bhardwaj M, Eftekhari T, Kilpatrick CD, Kirichenko A, Pal A, Cook AM, Gaensler BM, Giri U, Kaspi VM, Michilli D, Nimmo K, Pearlman AB, Pleunis Z, Sand KR, Stairs I, Andersen BC, Andrew S, Bandura K, Brar C, Cassanelli T, Chatterjee S, Curtin AP, Dong FA, Eadie G, Fonseca E, Ibik AL, Kaczmarek JF, Kharel B, Lazda M, Leung C, Li D, Main R, Masui KW, Mena-Parra J, Ng C, Pandhi A, Patil SS, Prochaska JX, Rafiei-Ravandi M, Scholz P, Shah V, Shin K, Smith K. Mckinven R, et al. Among authors: andersen bc. Nature. 2025 Jan;637(8044):43-47. doi: 10.1038/s41586-024-08184-4. Epub 2025 Jan 1. Nature. 2025. PMID: 39743599
Quantitative flow ratio versus fractional flow reserve for coronary revascularisation guidance (FAVOR III Europe): a multicentre, randomised, non-inferiority trial.
Andersen BK, Sejr-Hansen M, Maillard L, Campo G, Råmunddal T, Stähli BE, Guiducci V, Serafino LD, Escaned J, Santos IA, López-Palop R, Landmesser U, Dieu RS, Mejía-Rentería H, Koltowski L, Žiubrytė G, Cetran L, Adjedj J, Abdelwahed YS, Liu T, Mogensen LJH, Eftekhari A, Westra J, Lenk K, Casella G, Van Belle E, Biscaglia S, Olsen NT, Knaapen P, Kochman J, Santos RC, Scarsini R, Christiansen EH, Holm NR. Andersen BK, et al. Lancet. 2024 Nov 9;404(10465):1835-1846. doi: 10.1016/S0140-6736(24)02175-5. Epub 2024 Oct 30. Lancet. 2024. PMID: 39488224 Clinical Trial.
1,543 results